Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with Sanofi for its COVID-19 vaccine in ...
The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial ...
Shah Capital Management has withdrawn a proxy campaign against the re-election of directors at vaccines firm Novavax in the ...
Novavax (NVAX) stock surged after reaching a licensing agreement with Sanofi (SNY) for its COVID-19 vaccine and Matrix-M adjuvant. Read more here.
Novavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has ...
GAITHERSBURG, Md., May 30, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based ...
The COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller ...
The Biden administration's new tariffs on Chinese electric vehicles and other strategic sectors aim to protect the future of ...
Shares of vaccine stocks Moderna ( MRNA 1.58%), Novavax ( NVAX 2.31%), and BioNTech SE ( BNTX -2.07%) rallied this week, ...
Novavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company. This withdrawal is in ...
Sanofi (SNY) inks collaboration deal with Formation Bio and OpenAI to build AI-powered software to advance drug development ...
In the stock market, a back-from-the-dead story is equally appealing. Stocks that have been left for dead, or at least seen ...